Skip to main content

Approvals predictions & odds

·
Trump approval rating on July 3?

Trump approval rating on July 3?

98%

39.5–39.9

$10.3K Vol.

$5.5K Liq.

Trump approval rating on July 10?

Trump approval rating on July 10?

36%

<39.0

$131 Vol.

$1.0K Liq.

Ends in 7 days

Trump approval Up or Down this week?

Trump approval Up or Down this week?

93%

Up

$299 Vol.

$32 Liq.

Trump approval Up or Down this week?

Trump approval Up or Down this week?

50%

Up

$0 Vol.

$393 Liq.

Ends in 7 days

Trump approval Up or Down this week?

Trump approval Up or Down this week?

100%

Up

$15.9K Vol.

$0 Liq.

U.S. issues passport with Trump's face on it by July 31?

U.S. issues passport with Trump's face on it by July 31?

94%

$14.4K Vol.

$12.7K Liq.

Ends in 27 days

FDA approves Outlook Therapeutics' ONS-5010?

FDA approves Outlook Therapeutics' ONS-5010?

85%

$5.0K Vol.

$4.5K Liq.

Ends in 25 days

FDA approves Viatris' low-dose estrogen weekly patch?

FDA approves Viatris' low-dose estrogen weekly patch?

84%

$1.9K Vol.

$3.2K Liq.

Ends in 26 days

FDA approves Sanofi's Subcutaneous Sarclisa?

FDA approves Sanofi's Subcutaneous Sarclisa?

85%

$3.2K Vol.

$3.1K Liq.

Ends in 19 days

FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

14%

$575K Vol.

$6.8K Liq.

3

Ends in 6 months

US grants license for new nuclear reactor in 2026?

US grants license for new nuclear reactor in 2026?

21%

$24.1K Vol.

$2.1K Liq.

2

Ends in 6 months

Will McCormick merge with Unilever Foods by...?

Will McCormick merge with Unilever Foods by...?

78%

December 31, 2027

$578 Vol.

$2.1K Liq.

Ends in over 1 year

FDA approves Otsuka's Centanafadine?

FDA approves Otsuka's Centanafadine?

66%

$75 Vol.

$96 Liq.

Ends in 20 days

FDA approves Daraxonrasib this year?

FDA approves Daraxonrasib this year?

75%

$318 Vol.

$1.1K Liq.

Ends in 6 months

Trump Media x TAE Technologies merger closed by July 31?

Trump Media x TAE Technologies merger closed by July 31?

17%

$1 Vol.

$309 Liq.

Ends in 28 days

FDA approves Arcalyst technology transfer?

FDA approves Arcalyst technology transfer?

11%

$5.7K Vol.

$265 Liq.

FDA approves Celcuity's Gedatolisib?

FDA approves Celcuity's Gedatolisib?

70%

$0 Vol.

$85 Liq.

Ends in 13 days

FDA approves MannKind's FUROSCIX ReadyFlow Autoinjector?

FDA approves MannKind's FUROSCIX ReadyFlow Autoinjector?

42%

$176 Vol.

$59 Liq.

Ends in 22 days

FDA approves Vera Therapeutics' Atacicept?

FDA approves Vera Therapeutics' Atacicept?

88%

$431 Vol.

$83 Liq.

Ends in 3 days

FDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?

FDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?

59%

$20 Vol.

$72 Liq.

Ends in 19 days

Frequently Asked Questions

Polymarket is the world’s largest prediction market, where you can stay informed and profit from your knowledge by trading on things related to breaking news, politics, sports, elections, crypto, finance, tech, culture, including topics like Approvals.

Polymarket currently hosts 20 active markets for Approvals that lets you track or trade on predictions like “Trump approval rating on July 3?”. Whether you are tracking widely debated events or niche outcomes, the platform aggregates real-time odds based on over $658K in trading volume, providing a comprehensive view of fan and investor sentiment.

Each polymarket is a yes/no question, like “US grants license for new nuclear reactor in 2026?”. You buy shares in “yes” or “no” outcomes. Prices reflect crowd-sourced odds and probabilities. For example, if yes is at 30 cents, that’s a 30% chance. Markets resolve based on official results. For multi-outcome events, like “Trump approval rating on July 3?,” you simply trade on the specific outcome you think will win.

As of today, the most active market is “FDA approves Retatrutide this year?,” where the crowd is currently assigning a 86% chance to No. These odds update in real-time as new information emerges and users trade, offering a dynamic snapshot of what the market believes will happen compared to traditional bookmaker odds.

It cuts through the noise. Unlike polls or punditry, Polymarket shows you real-time odds on Approvals predictions backed by financial conviction that are often faster and more accurate than experts or surveys. You get an unbiased view of what thousands of traders think will actually happen, often more accurate than polls. Plus, you can trade shares and potentially profit if your predictions are spot on.